What I am worried about is NOT ONLY the potential damages (legal costs and damages claimed) BUT ALSO loss of sales (revenue!) in terms of clients taking their business to someone else (Pfizer and some other customers who may suspect quality control at PBP).
Anyway, "The subsidiary acquired the raw material from a reputable Australian third party supplier specifically approved by Pfizer to supply the material" so I hope they will be able to resolve this matter amicably. In the meantime, I have better use of my capital in other areas :-)
Bookmarks